Director, Quantitative Clinical Pharmacology: PK/PD Modeling & Strategy

Role: Lead clinical pharmacology and pharmacometrics for Sarepta's gene therapy programs, focusing on dose selection, PK/PD modeling, and translational approaches from early to late-stage development (Ph3 and registration). Responsibilities: develop and execute quantitative strategies, oversee data analysis including population PK/PD modeling, support regulatory interactions, and guide global regulatory strategies. Qualifications: PhD in Pharmaceutical Sciences, Mathematics, Engineering, or related field; 7+ years in clinical pharmacology or pharmacometrics; expertise with PK/PD modeling, regulatory engagements, and tools like NONMEM and R. Preferred: experience with siRNA, CNS, or translational science. HighValue: gene therapy, Duchenne muscular dystrophy, clinical pharmacology, PK/PD modeling, regulatory strategy, Ph3 development. WorkSetup: hybrid (US-based), on-site presence required; some in-person events.